Bluesky potential: MicroSalt®

Excess sodium consumption is a major contributor to hypertension and heart disease with a big part of the typical person’s intake hidden in processed foods. With this health crisis front of mind, the WHO has set a target for slashing global sodium consumption by 30% by 2025, which it estimates will save 7 million lives by 2030.

One market minnow on a mission to reduce sodium consumption and heart disease is MicroSalt (SALT:AIM), producer of a patented full-flavour, low-sodium salt for food manufacturers and consumers that is strengthening its intellectual property position and could reward a punt if its technology fulfils its tasty potential over the next decade, though the market newcomer is no stock for widows and orphans.

Read full article here.

More To Explore

Scroll to Top

Let's connect!

Please, leave your contact info; We’ll be in touch shortly

Before you go!

Please, leave your contact info; We’ll be in touch shortly